Moshav Ganei, Israel

Oren Bogin

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 158(Granted Patents)


Location History:

  • Ganei Yohanan, IL (2007)
  • Moshav Ganei Yohanan, IL (2007)
  • Tel Aviv, IL (2014)
  • Moshav Ganei, IL (2009 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Oren Bogin: Pioneering Innovations in Bone Treatment

Introduction

Oren Bogin, an innovative inventor based in Moshav Ganei, Israel, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 7 patents, his work primarily focuses on fibroblast growth factors and their applications in treating skeletal disorders.

Latest Patents

Among his latest patents, Oren Bogin has developed methods related to FGF-2 variants, specifically targeting individuals with abnormal bone conditions or disorders related to FGF receptors. His detailed approach includes administering a pharmaceutical composition that comprises a therapeutically effective amount of a fibroblast growth factor 9 (FGF-9) variant. This innovative method incorporates specific amino acid substitutions within the beta 8-beta 9 loop, utilizing sequences set forth in molecular identifiers such as SEQ ID NO: 11, 13, 14, 15, 16, or 17. This groundbreaking research aims to provide new treatment avenues for individuals suffering from dysplasic bone and related disorders.

Career Highlights

Oren Bogin's career is marked by his association with prominent organizations, including Prochon Biotech Ltd. and Yeda Research and Development Company Limited. His work in these companies has positioned him at the forefront of innovative research in biomedical science, particularly in therapies aimed at enhancing bone health.

Collaborations

Throughout his career, Oren has collaborated with notable colleagues such as Avner Yayon and Rivka Adar, contributing to a collaborative environment that fosters creativity and innovation. Their combined expertise has likely played a crucial role in advancing their mutual goals in the field of biotechnology.

Conclusion

Oren Bogin exemplifies the spirit of innovation in the realm of medical treatments for bone disorders. His significant contributions through patents and collaborations continue to pave the way for advancements in therapeutic methodologies, offering hope and improved quality of life for patients facing skeletal challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…